argenx SE

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell argenx SE and other ETFs, options, and stocks.

About ARGX

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. 

CEO
Tim van Hauwermeiren
CEOTim van Hauwermeiren
Employees
1,599
Employees1,599
Headquarters
Amsterdam, Noord-Holland
HeadquartersAmsterdam, Noord-Holland
Founded
2008
Founded2008
Employees
1,599
Employees1,599

ARGX Key Statistics

Market cap
36.92B
Market cap36.92B
Price-Earnings ratio
42.29
Price-Earnings ratio42.29
Dividend yield
Dividend yield
Average volume
525.20K
Average volume525.20K
High today
$600.93
High today$600.93
Low today
$590.80
Low today$590.80
Open price
$591.34
Open price$591.34
Volume
301.21K
Volume301.21K
52 Week high
$678.21
52 Week high$678.21
52 Week low
$352.77
52 Week low$352.77

ARGX News

Benzinga 6d
FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting

The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s ARGX Vyvgart Hytrulo with a prefilled syri...

FDA Approves Argenx's Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting

Analyst ratings

88%

of 34 ratings
Buy
88.2%
Hold
11.8%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.